Evidence map›Paper›PMID 23996541›Full record

ReviewCurrent allergy and asthma reports2013

Understanding the role of Tbx1 as a candidate gene for 22q11.2 deletion syndrome.

Shan Gao, Xiao Li, Brad A Amendt

Abstract readReview
In one paragraph

Review in Current allergy and asthma reports, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 35 papers.

0numbers the graph read from it
0cells of the map it votes in
35citing papers in PubMed
2.2field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

35 citing papers in PubMed, 72 citations in OpenAlex.

  1. Hypoparathyroidism with aJCEM case reports · 2026
    Article
  2. Article
  3. Article
  4. Identification of a NovelDiagnostics (Basel, Switzerland) · 2025
    Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Perspectives on the Parathyroid-Thymus Interconnection-A Literature Review.International journal of molecular sciences · 2025
    Review
  10. Review
  11. Article
  12. Article
  13. Human Genetics of Semilunar Valve and Aortic Arch Anomalies.Advances in experimental medicine and biology · 2024
    Review
  14. Article
  15. Article
  16. Review
  17. Review
  18. Article
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 1 country.

Shan GaoInstitute of Biosciences and Technology, Texas A&M University Health Science Center, Houston, TX, USA.
Xiao Li
Brad A Amendt
University of Iowa · USTexas A&M Health Science Center · US

Funding

Molecular Mechanisms of PITX2 During Craniofacial DevelopmentR01DE013941 · NIDCR · UNIVERSITY OF TULSA · PI AMENDT, BRAD A · 2000 to 2013
$4.2M
Mechanisms of FoxJ1 Tooth MorphogenesisR01DE018885 · NIDCR · UNIVERSITY OF IOWA · PI AMENDT, BRAD A · 2009 to 2012
$1.5M
NIDCR NIH HHS DE013941NIDCR NIH HHS DE018885NIDCR NIH HHS R01 DE013941NIDCR NIH HHS R01 DE018885
6 · The paper itself

Abstract

22q11.2 deletion syndrome (22q11.2DS) is caused by a commonly occurring microdeletion on chromosome 22. Clinical findings include cardiac malformations, thymic and parathyroid hypoplasia, craniofacial dysmorphisms, and dental defects. These phenotypes are due mainly to abnormal development of the pharyngeal apparatus. Targeted deletion studies in mice and analysis of naturally occurring mutations in humans have implicated Tbx1 as a candidate gene for 22q11.2DS. Tbx1 belongs to an evolutionarily conserved T-box family of transcription factors, whose expression is precisely regulated during embryogenesis, and it appears to regulate the proliferation and differentiation of various progenitor cells during organogenesis. In this review, we discuss the mechanisms of Tbx1 during development of the heart, thymus and parathyroid glands, as well as during formation of the palate, teeth, and other craniofacial features.

Indexed as

AnimalsChromosomes, Human, Pair 22DiGeorge SyndromeGene Expression RegulationHumansMutationPhenotypeT-Box Domain ProteinsT-Box Domain ProteinsTBX1 protein, human

Identifiers

PMID23996541
PMCPMC3840116
OpenAlexW2048900407

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.